Over 40% of newly approved drugs in 2024 were biologics, many of which require cold or ultra-cold storage to temperatures as low as –80°C [1]. However, label adhesives often struggle in ultra-cold conditions, resulting in failures that can jeopardize clinical trials. With a lack of qualified suppliers of labels in the market, Thermo Fisher Scientific ran an internal validation study of its ultra-low temperature labels, in which multiple label formats were tested for their standards for qualification. Read the study to learn more.
[1] https://www.eawlogistics.com/smart-ultra-cold-and-scalable-the-future-of-pharma-cold-storage/